Skip to main content

Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims

The consumer health and pharma giant still managed to beat earnings estimates, raise its guidance and boost its dividend.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.